Skip to content
Search

Latest Stories

Asian women shun cervical screening over Covid worries, say experts

by LAUREN CODLING

SOUTH ASIAN women are the least likely to attend cervical screening appointments due to concerns about Covid-19, a report found this month.


Research from charity Jo’s Cervical Cancer Trust showed that a third of women from a south Asian background do not think it is safe to visit a GP surgery at the moment. It also found that two-thirds of south Asian women believed it was best to delay cervical screening if they were at higher risk of coronavirus, while 90 per cent of them expressed concerns about catching the infection.

Professor Minaxi Desai, a trustee for Jo’s Cervical Cancer Trust, said the fear of contracting Covid has become an additional barrier for Asian women, as previous research showed many had voiced reluctance to engage with the screening service.

“Research has already shown the fear voiced by south Asian women, but now coronavirus has been shown to be a barrier too,” she told Eastern Eye on Monday (23). “There is the worry of catching coronavirus, as well as the fear of the screening and not knowing exactly what is involved in smear taking.”

Desai was previously the clinical director of the Manchester Cytology Centre at the Manchester Royal Infirmary, the largest cervical screening laboratory in Europe. She said concerns could be attributed to cultural barriers or the fear of embarrassment, discomfort or pain.

The research corroborated Desai’s view, as it highlighted a number of issues which contributed to south Asian women’s hesitation to schedule a screening. These included pressure not to go before they were married, concerns over being examined by a male doctor and a lack of education about the procedure.

Many south Asian women who were interviewed for the survey said they had never attended a screening. A 36-year-old British Pakistani said she did not “feel mentally prepared for it”. “I can’t bring myself to do it,” she said. An Indian, aged 26, also admitted she had not had a cervical smear test. She said the issue was not spoken about in her community and, to her knowledge, none of her Asian friends had been checked. “My sister is 36 and I don’t think she’s ever been (checked),” she added.

Another woman, of Pakistani origin, agreed her community did not tend to talk about issues relating to smear tests or reproductive issues. “It’s just not talked about,” she said. “(My community) don’t really talk about screening or HPV (a viral infection, picked up by cervical smears). My white friends talk about it, though.”

Desai also believes that many Asian women are afraid to visit their GP during the pandemic, for fear of picking up the virus and potentially passing it onto family members. “(Within the Asian community), there

are many families living together in multi-generational households,” she said. “It is known that the elderly generation is at higher risk (of catching the virus), which could make people even more afraid of catching the virus and bringing it home with them.”

The research showed 93 per cent of south Asian women were the most worried about the risk of the virus to loved ones. In order to encourage screenings within the Asian community, Desai highlighted the work of community engagement projects. In particular, she noted the Answer Cancer awareness scheme being run in Greater Manchester, which aims to increase uptake of cancer screening across the region.

The programme has helped to initiate Answer Cancer Champions – a growing network of people who are encouraged to share information related to cancer among family, friends, colleagues and the local community. Champions are provided with training, so they have access to the correct information and guidance.

Desai believes that the community engagement approach can help to  ease the fears of women, who may not necessarily want to discuss their problems with a medical professional. “We know there are these cultural barriers, which are making (women) think twice before going for screening”, she said. “But (information) from a community champion gets people talking. I believe the bottom-up approach currently used in Manchester really helps."

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less